methylselenic acid has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, G; Jiang, K; Qiu, C; Qiu, J; Wu, H; Zhang, T; Zhao, G; Zhu, X | 1 |
| Gopalakrishna, R; Gottlieb, SN; Gundimeda, U; Roth, BI; Schiffman, JE | 1 |
| Chung, AS; Kim, A; Oh, JH; Park, JM | 1 |
3 other study(ies) available for methylselenic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Janus Kinase 2; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Organoselenium Compounds; Signal Transduction; STAT3 Transcription Factor | 2019 |
Negation of the cancer-preventive actions of selenium by over-expression of protein kinase Cepsilon and selenoprotein thioredoxin reductase.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Humans; Indoles; Male; Maleimides; Methylnitrosourea; Neoplasm Invasiveness; Organoselenium Compounds; Prostatic Neoplasms; Protein Kinase C-epsilon; Thioredoxin-Disulfide Reductase | 2009 |
Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Topics: Carcinogens; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Precursors; Fibrosarcoma; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Organoselenium Compounds; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured | 2007 |